| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2125.1977.TB04509.X |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1428838 |
| https://europepmc.org/articles/PMC1428838?pdf=render | ||
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1977.tb04509.x | ||
| http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1977.tb04509.x/fullpdf | ||
| P932 | PMC publication ID | 1428838 |
| P698 | PubMed publication ID | 406909 |
| P5875 | ResearchGate publication ID | 22734988 |
| P2093 | author name string | P. W. Majerus | |
| N. Stanford | |||
| P2860 | cites work | The binding of thrombin to the surface of human platelets. | Q38361276 |
| Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions | Q40050412 | ||
| Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin | Q41254340 | ||
| Effects of salicylates on human platelets. | Q54102846 | ||
| Thromboxanes: selective biosynthesis and distinct biological properties | Q67769711 | ||
| Editorial: Why aspirin? | Q67773550 | ||
| Properties of a novel preparation of prostaglandin synthetase from sheep seminal vesicles | Q93826100 | ||
| The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein | Q34481430 | ||
| Acetylation of prostaglandin synthase by aspirin | Q35085661 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| pharmacology | Q128406 | ||
| cyclooxygenase inhibitors | Q20522059 | ||
| P304 | page(s) | 15S-18S | |
| P577 | publication date | 1977-02-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles | |
| P478 | volume | 4 Suppl 1 |
| Q45949561 | Comparison of Fecal Blood Loss after Use of Aspirin and Diflunisal. |
| Q71539428 | Different sensitivities of prostaglandin-cyclooxygenases in blood platelets and coronary arteries against non-steroidal antiinflammatory drugs |
| Q57424497 | Diflunisal |
| Q29042543 | Diflunisal - a long-acting non-steroidal anti-inflammatory drug. |
| Q33551874 | Diflunisal in osteoarthrosis of the hip and knee |
| Q70189473 | Diflunisal in rheumatoid arthritis |
| Q28323987 | Diflunisal, a New-Acting Analgesic and Prostaglandin Inhibitor: Effect of Concomitant Acetylsalicylic Acid Therapy on Ototoxicity and on Disposition of Both Drugs |
| Q39677355 | Diflunisal, a new analgesic, in the treatment of postoperative pain following removal of impacted mandibular third molars |
| Q42251061 | Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits |
| Q28276373 | Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis |
| Q40786992 | Discovery of diflunisal |
| Q50122529 | Effects of Diflunisal on Platelet Function and Fecal Blood Loss |
| Q55060619 | Evaluation of preoperative diflunisal for postoperative pain following periodontal surgery. |
| Q66703348 | Gastrointestinal haemorrhage associated with diflunisal |
| Q34454444 | Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock |
| Q44418107 | Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal |
| Q42731074 | Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis |
| Q35340019 | Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents |
| Q35006714 | New aspects on efficient anticoagulation and antiplatelet strategies in sheep |
| Q68111026 | Pharmacokinetics of intraarticular indomethacin in patients with osteoarthritis |
| Q34515111 | Pharmacology and toxicology of diflunisal |
| Q40661766 | Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats |
| Q40116249 | Prostaglandins and the Inflammatory Response |
| Q50122510 | Review of the Animal and Clinical Pharmacology of Diflunisal |
| Q35996712 | Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin |
| Q39707048 | Some Medicinal Chemical Aspects of Prostaglandin Synthesis Inhibitors |
| Q40943058 | The analgesic and anti- inflammatory efficacy of diflunisal and Codeine after removal of impacted third molars |
| Q39773990 | The chemistry, pharmacology and clinical pharmacology of diflunisal |
| Q36096323 | The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2 |
Search more.